Patients undergoing elective C-section will be randomized into two groups. The first group will receive one dose of Betamethasone at least 24 hours before scheduled C-section. The second group will receive placebo.
This is a prospective double blinded randomized clinical trial. Patients will be randomized into two groups. Group A will receive one dose of Betamethasone at least 24 hours before scheduled C-section. Group B will receive placebo. The maternal and neonatal outcomes will be studied in order to assess the effect of Betamethasone on respiratory morbidity of the newborn infant.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Enrollment
400
A single injection will be administered to the patient at least 24 hours before undergoing C-section. This injection will be prepared in the hospital's pharmacy to contain betamethasone
A single injection will be administered to the patient. This injection will be prepared in the hospital's pharmacy to contain normal saline.
Makassed General Hospital
Beirut, Lebanon
RECRUITINGPercentage of patients with respiratory morbidity
Neonatal respiratory morbidity will be assessed through oxygen saturation, Apgar score and Silverman score
Time frame: at birth
Admission to Neonatal Intensive Care Unit (NICU)
Reasons for NICU admission and length of stay
Time frame: up to 2 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.